{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:38:12Z","timestamp":1782844692308,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170316"],"award-info":[{"award-number":["82170316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200520"],"award-info":[{"award-number":["82200520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.intimp.2023.111038","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:36:08Z","timestamp":1698572168000},"page":"111038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["Dapagliflozin attenuates the vulnerability to atrial fibrillation in rats with lipopolysaccharide-induced myocardial injury"],"prefix":"10.1016","volume":"125","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiukun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-4198","authenticated-orcid":false,"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2023.111038_b0005","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00134-016-4577-z","article-title":"Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy","volume":"42","author":"Perner","year":"2016","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/bja\/aep339","article-title":"Sepsis and the heart","volume":"104","author":"Hunter","year":"2010","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13054-018-2043-8","article-title":"Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature","volume":"22","author":"Ehrman","year":"2018","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.intimp.2023.111038_b0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111038_b0025","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00134-015-3748-7","article-title":"Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis","volume":"41","author":"Sanfilippo","year":"2015","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-018-2113-y","article-title":"Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis","volume":"22","author":"Sanfilippo","year":"2018","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.intimp.2023.111038_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2023.111038_b0040","doi-asserted-by":"crossref","first-page":"7393525","DOI":"10.1155\/2017\/7393525","article-title":"Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage","volume":"2017","author":"Tsolaki","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.intimp.2023.111038_b0045","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00134-018-5175-z","article-title":"Surviving sepsis campaign: research priorities for sepsis and septic shock","volume":"44","author":"Coopersmith","year":"2018","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2023.111038_b0050","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fimmu.2017.01021","article-title":"Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.111038_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2021.10.022","article-title":"Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?","volume":"98","author":"Induruwa","year":"2022","journal-title":"Eur. J. Intern. Med."},{"issue":"10","key":"10.1016\/j.intimp.2023.111038_b0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"issue":"24","key":"10.1016\/j.intimp.2023.111038_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413384","article-title":"Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases","volume":"22","author":"Kowalczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111038_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106027","article-title":"Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments","volume":"175","author":"Liu","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.111038_b0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/FJC.0000000000000313","article-title":"Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update","volume":"66","author":"Gutierrez","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111038_b0080","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.111038_b0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/eurheartj\/ehn011","article-title":"N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study","volume":"29","author":"Ozaydin","year":"2008","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.intimp.2023.111038_b0090","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jacc.2013.07.014","article-title":"A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement","volume":"62","author":"Rodrigo","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111038_b0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2174\/1871530320666200728152307","article-title":"The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial","volume":"21","author":"Barati","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.intimp.2023.111038_b0100","doi-asserted-by":"crossref","first-page":"2468031","DOI":"10.1155\/2020\/2468031","article-title":"Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats","volume":"2020","author":"Gong","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.111038_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173614","article-title":"Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats","volume":"889","author":"Fo","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2023.111038_b0110","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.3390\/ijms150814803","article-title":"Simvastatin attenuates the oxidative stress, endothelial thrombogenicity and the inducibility of atrial fibrillation in a rat model of ischemic heart failure","volume":"15","author":"Cho","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2023.111038_b0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2023.111038_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106448","article-title":"Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes","volume":"184","author":"Marfella","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.111038_b0125","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/cvr\/cvab271","article-title":"Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"13","key":"10.1016\/j.intimp.2023.111038_b0130","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40265-021-01573-3","article-title":"A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease","volume":"81","author":"Del Vecchio","year":"2021","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.intimp.2023.111038_b0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2023.111038_b0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-023-01754-2","article-title":"Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors","volume":"22","author":"Scisciola","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dom.14211","article-title":"Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials","volume":"23","author":"Okunrintemi","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.intimp.2023.111038_b0155","doi-asserted-by":"crossref","first-page":"e019274","DOI":"10.1161\/JAHA.120.019274","article-title":"Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction","volume":"10","author":"Lin","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.intimp.2023.111038_b0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ehf2.14169","article-title":"Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease","volume":"10","author":"Dai","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.intimp.2023.111038_b0165","doi-asserted-by":"crossref","first-page":"e017483","DOI":"10.1161\/JAHA.119.017483","article-title":"Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model","volume":"10","author":"Nishinarita","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.intimp.2023.111038_b0170","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1111\/jcmm.12871","article-title":"Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K\/Akt\/mTOR pathway in vitro and in vivo","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2023.111038_b0175","doi-asserted-by":"crossref","unstructured":"Hsieh, P.L., et al., Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation. Int J Mol Sci, 2022. 23(17).","DOI":"10.3390\/ijms231710146"},{"key":"10.1016\/j.intimp.2023.111038_b0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.intimp.2023.111038_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174715","article-title":"Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-\u03baB activation in human endothelial cells and differentiated macrophages","volume":"918","author":"Abdollahi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.111038_b0190","doi-asserted-by":"crossref","unstructured":"Alanazi, W.A., et al., Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level. Pharmaceutics, 2023. 15(6).","DOI":"10.3390\/pharmaceutics15061683"},{"issue":"10","key":"10.1016\/j.intimp.2023.111038_b0195","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1177\/1060028013500938","article-title":"Challenges of anticoagulation for atrial fibrillation in patients with severe sepsis","volume":"47","author":"Darwish","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2023.111038_b0200","doi-asserted-by":"crossref","unstructured":"Kuipers, S., P.M. Klein Klouwenberg, and O.L. Cremer, Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care, 2014. 18(6): p. 688.","DOI":"10.1186\/s13054-014-0688-5"},{"key":"10.1016\/j.intimp.2023.111038_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155243","article-title":"SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study","volume":"137","author":"Sardu","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2023.111038_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2017.03.005","article-title":"The role of the autonomic nervous system in arrhythmias and sudden cardiac death","volume":"205","author":"Franciosi","year":"2017","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.intimp.2023.111038_b0215","doi-asserted-by":"crossref","first-page":"1012220","DOI":"10.3389\/fcvm.2022.1012220","article-title":"In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study","volume":"9","author":"Cesaro","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.intimp.2023.111038_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.908037","article-title":"Sodium-glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway","volume":"9","author":"Zhan","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.intimp.2023.111038_b0225","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.102.20.2503","article-title":"Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness","volume":"102","author":"Sticherling","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.111038_b0230","doi-asserted-by":"crossref","unstructured":"Franz, M.R., S.M. Jamal, and S.M. Narayan, The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directions. Europace, 2012. 14 Suppl 5(Suppl 5): p. v58-v64.","DOI":"10.1093\/europace\/eus273"},{"issue":"2","key":"10.1016\/j.intimp.2023.111038_b0235","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.00014.2006","article-title":"Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation","volume":"87","author":"Nattel","year":"2007","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2023.111038_b0240","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3904\/kjim.2010.25.4.377","article-title":"Remodeling of ion channel expression in patients with chronic atrial fibrillation and mitral valvular heart disease","volume":"25","author":"Oh","year":"2010","journal-title":"Korean J. Intern. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.111038_b0245","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/eurheartj\/ehn140","article-title":"Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation","volume":"29","author":"Dinanian","year":"2008","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.intimp.2023.111038_b0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/FJC.0000000000000781","article-title":"Circulating Mesencephalic Astrocyte-Derived Neurotrophic Factor Negatively Correlates With Atrial Apoptosis in Human Chronic Atrial Fibrillation","volume":"75","author":"Wang","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111038_b0255","first-page":"1745","article-title":"Upregulation of miR-122 is associated with cardiomyocyte apoptosis in atrial fibrillation","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"16","key":"10.1016\/j.intimp.2023.111038_b0260","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/CIRCULATIONAHA.113.005837","article-title":"Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle","volume":"128","author":"Yang","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.111038_b0265","doi-asserted-by":"crossref","first-page":"9656078","DOI":"10.1155\/2016\/9656078","article-title":"Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress","volume":"2016","author":"Sovari","year":"2016","journal-title":"Cardiol. Res. Pract."},{"issue":"7","key":"10.1016\/j.intimp.2023.111038_b0270","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.CIR.97.7.651","article-title":"Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle","volume":"97","author":"Kaprielian","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.intimp.2023.111038_b0275","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/cvr\/cvm083","article-title":"Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1","volume":"77","author":"Bruce","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2023.111038_b0280","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111038_b0285","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00210-017-1457-1","article-title":"DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure","volume":"391","author":"Qiu","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:05:39Z","timestamp":1761588339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923013644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":57,"alternative-id":["S1567576923013644"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111038","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates the vulnerability to atrial fibrillation in rats with lipopolysaccharide-induced myocardial injury","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111038"}}